Methods for inhibiting or reducing mucositis associated with...

Details Methods for inhibiting or reducing mucositis associated with... Methods for inhibiting or reducing mucositis associated with...

A - Human Necessities

61

N

A61N 5/06 (2006.01) A61B 19/00 (2006.01)

Patent

CA 2188947

Prevention or treatment of mucositis in bone marrow transplant patients is achieved by administering laser energy to the affected tissue, the laser light beam being characterized by a wavelength of 630 to 950 nanometers at about 10 to 60 milliwatts and applied to the tissue at the rate of 0.5 to 2.0 joules per cm. Periodic treatments before, during and/or after conditioning with agents such as cyclophosphamide and TBI result in reduction of severity of symptoms observed in mucositis.

La prévention ou le traitement des inflammations des muqueuses chez les patients receveurs de moëlle osseuse se pratique par l'administration d'énergie laser au niveau des tissus touchés. Le faisceau lumineux du laser est caractérisé par une longueur d'onde de 630 à 950 nm, pour une puissance d'environ 10 à 60 mW est appliqué sur le tissu à raison de 0,5 à 2 j/cm<2>. Les traitements périodiques avant, pendant et/ou après conditionnement par des agents tels que le cyclophosphamide et le TBI permettent d'atténuer les symptômes d'inflammation observés sur les muqueuses.

Affiliated with

Also associated with

Rating

Methods for inhibiting or reducing mucositis associated with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for inhibiting or reducing mucositis associated with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for inhibiting or reducing mucositis associated with... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1874920